As of Aug 26
| +0.16 / +2.29%|
The 3 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a -57.98% decrease from the last price of 7.14.
The current consensus among 4 polled investment analysts is to Hold stock in Rockwell Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.